Experienced in Temporal Arteritis

Dario Roccatello

Coordinating Center Of The Network For Rare Diseases Of Piedmont And Aosta Valley, 
Turin, IT 
Experienced in Temporal Arteritis
Coordinating Center Of The Network For Rare Diseases Of Piedmont And Aosta Valley, 
Turin, IT 
OverviewLocationsClinical Research

Overview

Dario Roccatello practices in Turin, Italy. Mr. Roccatello is rated as an Experienced expert by MediFind in the treatment of Temporal Arteritis. His top areas of expertise are Glomerulonephritis, Antiphospholipid Syndrome, Lupus Nephritis, Systemic Lupus Erythematosus (SLE), and Nephrectomy.

His clinical research consists of co-authoring 315 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Temporal Arteritis.

Gender
Male

Locations

Coordinating Center Of The Network For Rare Diseases Of Piedmont And Aosta Valley, Turin, 10154, Italy
Other Locations
Coordinating Center Of The Interregional Network Of Rare Diseases Of Piedmont And Aosta Valley, Turin, 10154, Italy
Interregional Coordinating Center Of The Network Of Rare Diseases Of Piedmont And Aosta Valley, Turin, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 22, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
View 1 Less Clinical Trial

315 Total Publications

Hopes and concerns of CAR-T cell regimens in systemic lupus erythematosus and other immune mediated diseases.
Hopes and concerns of CAR-T cell regimens in systemic lupus erythematosus and other immune mediated diseases.
Journal: Lupus
Published: September 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Roccatello's expertise for a condition
ConditionClose
View All 8 Elite Conditions
View All 19 Advanced Conditions
View All 58 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile